BMC Medical Genomics (Apr 2021)

Validation of whole genome sequencing from dried blood spots

  • Pooja Agrawal,
  • Shanmukh Katragadda,
  • Arun K. Hariharan,
  • Vijayashree Gauribidanur Raghavendrachar,
  • Arunika Agarwal,
  • Rashmi Dayalu,
  • Disha Awasthy,
  • Sanjay C. Sharma,
  • Yasodha Kannan Sivasamy,
  • P. Lakshmana,
  • Ashwini Shanmugam,
  • Vamsi Veeramachaneni,
  • Vaijayanti Gupta,
  • B. P. Vani,
  • Lekha Subaiya,
  • T. S. Syamala,
  • Ramesh Hariharan,
  • Vijay Chandru,
  • David E. Bloom

DOI
https://doi.org/10.1186/s12920-021-00951-w
Journal volume & issue
Vol. 14, no. 1
pp. 1 – 11

Abstract

Read online

Abstract Background Dried blood spots (DBS) are a relatively inexpensive source of nucleic acids and are easy to collect, transport, and store in large-scale field surveys, especially in resource-limited settings. However, their performance in whole-genome sequencing (WGS) relative to that of venous blood DNA has not been analyzed for various downstream applications. Methods This study compares the WGS performance of DBS paired with venous blood samples collected from 12 subjects. Results Results of standard quality checks of coverage, base quality, and mapping quality were found to be near identical between DBS and venous blood. Concordance for single-nucleotide variants, insertions and deletions, and copy number variants was high between these two sample types. Additionally, downstream analyses typical of population-based studies were performed, such as mitochondrial heteroplasmy detection, haplotype analysis, mitochondrial copy number changes, and determination of telomere lengths. The absolute mitochondrial copy number values were higher for DBS than for venous blood, though the trend in sample-to-sample variation was similar between DBS and blood. Telomere length estimates in most DBS samples were on par with those from venous blood. Conclusion DBS samples can serve as a robust and feasible alternative to venous blood for studies requiring WGS analysis.

Keywords